Status:
COMPLETED
Metabotyping in the Postmenopausal Stage
Lead Sponsor:
Fundació Eurecat
Conditions:
Menopause
Postmenopausal Disorder
Eligibility:
FEMALE
40-63 years
Brief Summary
Menopause is defined as the absence of menstrual periods for twelve consecutive months. Although the onset may vary, natural menopause occurs between the ages of 45 and 55 and is considered a stage in...
Detailed Description
Cross-sectional observational study in which samples of blood, faeces, urine, hair and hair follicles will be collected to characterize the metabolic profile, intestinal microbiota (IM), gene expressi...
Eligibility Criteria
Inclusion
- Women between 40 and 63 years old with amenorrhea for a period of time equal or greater than 12 months.
- Without hormone replacement therapy.
- Sign the informed consent.
Exclusion
- Women diagnosed with diabetes (or serum glucose ≥ 126 mg/dL) or other chronic pathologies (coronary, cardiovascular, celiac disease, Crohn's disease and chronic kidney diseases (or serum creatinine ≥ 1.5 mg/dL).
- Women taking medications prescribed for hypertension and dyslipidemia. Women who have consumed during the week prior to start to start of the study anti-inflammatory drugs.
- women with chronic gastrointestinal problems.
- Women with a body mass index (in kg/m2) \<18 or ≥35.
- Women who are participating in another clinical trial or following a prescribed diet for any reason, including weigh loss, during the last month.
- Women who consume more than 14 alcoholic beverages per week.
- Women current smokers.
Key Trial Info
Start Date :
April 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05397015
Start Date
April 16 2021
End Date
November 29 2022
Last Update
March 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eurecat
Reus, Spain, 43204